People · Operator

Marvin M Hullet

Named in public records as an officer, director or promoter · active 2007–2007 · Pharmaceuticals

1
Companies
1
Filings
$3.8M
Combined raised · real
Single
Operator type
Companies
CompanyRoleSectorStageRaised · realValue · estTied
Trilogic Pharma LlcPharmaceuticalsSeed$3.8M$8.5M2007
Operator network

Marvin M Hullet at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.

JAMES A. H. HARWICK · 2 companies · 1 sharedJAMES A. H. HARWI…ALEXANDER H. C. HARWICK · 1 companies · 1 sharedALEXANDER H. C. H…DANIEL P. WILBANKS · 1 companies · 1 sharedDANIEL P. WILBANKSDaniel P. Willbanks · 1 companies · 1 sharedDaniel P. Willban…ERNEST C. HORNSBY · 1 companies · 1 sharedERNEST C. HORNSBYHemant H Alur · 1 companies · 1 sharedHemant H AlurHERMANT H. ALUR · 1 companies · 1 sharedHERMANT H. ALURJames A. Harwick · 1 companies · 1 sharedJames A. HarwickMark S. Paxton · 1 companies · 1 sharedMark S. PaxtonRANDY B. STANLEY · 1 companies · 1 sharedRANDY B. STANLEYWESLEY R. HEATON · 1 companies · 1 sharedWESLEY R. HEATONWILLIAM C. MAICHLE · 1 companies · 1 sharedWILLIAM C. MAICHLEWILLIAM VAN HOOSER · 1 companies · 1 sharedWILLIAM VAN HOOSERTrilogic Pharma Llc · $3.8M raisedTrilogic Pharma LlcMarvin M HulletMH
Marvin M Hullet Company Co-operator (ring = serial)Hover to isolate ties · click to open
Co-operators (shared boards)

People named alongside Marvin M Hullet on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.

OperatorSharedTheir companies
JAMES A. H. HARWICK12
HERMANT H. ALUR11
WILLIAM VAN HOOSER11
WILLIAM C. MAICHLE11
ERNEST C. HORNSBY11
WESLEY R. HEATON11
RANDY B. STANLEY11
ALEXANDER H. C. HARWICK11
DANIEL P. WILBANKS11
Mark S. Paxton11
Daniel P. Willbanks11
James A. Harwick11
Hemant H Alur11

People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.